Risks of Popular Weight Loss Drugs: Digestive Problems and Serious Side Effects

Weight loss drugs that mimic the hormone GLP-1 to suppress appetite may be linked to digestive problems, including pancreatitis, gastroparesis, and bowel obstruction, according to a study analyzing data from over 5,000 patients. While the risk is relatively small, with a four-fold increase in certain complications compared to non-GLP-1 medications, the growing number of people taking these drugs raises concerns. GLP-1 medications slow down digestion and manage blood glucose levels, but the study focused on their weight loss effects in non-diabetic obese patients. The research highlights the need for further investigation and consideration of the risk-benefit balance for individuals considering these drugs for weight loss.